Farb Daniel Stuart 13D and 13G filings for Lumos Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-20 06:05 am Sale | 2023-06-16 | 13D | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 400,000 4.900% | -96,891 (-19.50%) | Filing |
| 2023-06-02 11:14 am Sale | 2023-05-30 | 13D | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 496,891 6.080% | -146,447 (-22.76%) | Filing |
| 2023-05-25 12:10 pm Sale | 2023-05-24 | 13D | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 643,338 7.870% | -116,662 (-15.35%) | Filing |
| 2023-02-14 6:25 pm Unchanged | 2023-02-13 | 13D | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 760,000 9.070% | 0 (Unchanged) | Filing |
| 2023-01-24 12:58 pm Purchase | 2023-01-25 | 13G | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 760,000 9.070% | 263,189 (+52.98%) | Filing |
| 2022-02-02 2:44 pm Unchanged | 2022-01-27 | 13G | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 496,811 5.940% | 0 (Unchanged) | Filing |
| 2022-01-31 5:34 pm Purchase | 2022-01-27 | 13G | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 496,811 5.940% | 496,811 (New Position) | Filing |